251 filings
Page 5 of 13
8-K
xlb pbb4bukd
15 Oct 21
Departure of Directors or Certain Officers
4:36pm
8-K
l6c wypk8
29 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
ok20c
28 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
xbnqeis36f8k
12 Jul 21
Other Events
8:14am
8-K
d5yqxt qut51
28 Jun 21
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA⢠Immunogene Therapy
4:22pm
8-K
qwn26w4ghwzu7c6yea
13 May 21
Other Events
4:58pm
DEFA14A
788ybdxxj0svhvrxb
30 Apr 21
Additional proxy soliciting materials
4:11pm
8-K
exjouxc9ermfb
25 Mar 21
Departure of Directors or Certain Officers
4:24pm
8-K
ux0cwrgv
9 Mar 21
Entry into a Material Definitive Agreement
9:06am
8-K
wpglcl ow6
2 Mar 21
Other Events
4:44pm
424B5
rbdkmwn1m5jrptlpxw0
10 Feb 21
Prospectus supplement for primary offering
4:32pm
8-K
6fv691lo4693wtzt4cl0
9 Feb 21
Genprex, Inc. Announces $25 Million
4:59pm
8-K
hlk0j6
28 Jan 21
Other Events
4:30pm
8-K
crhtmd62pi
23 Dec 20
Genprex, Inc. Announces $12 Million
4:41pm
424B5
x9023w62sgdavzhrz
23 Dec 20
Prospectus supplement for primary offering
4:32pm
8-K
5pbdwyt7tbp7yekks
16 Nov 20
Other Events
4:33pm